BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38090112)

  • 1. MicroRNA-503 Inhibits Non-Small Cell Lung Cancer Progression by Targeting PDK1/PI3K/AKT Pathway [Retraction].
    Onco Targets Ther; 2023; 16():1023-1024. PubMed ID: 38090112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-Regulation of SREBP via PI3K/AKT/mTOR Pathway Inhibits the Proliferation and Invasion of Non-Small-Cell Lung Cancer Cells [Retraction].
    Onco Targets Ther; 2022; 15():1039-1040. PubMed ID: 36176731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-503 Inhibits Non-Small Cell Lung Cancer Progression By Targeting PDK1/PI3K/AKT Pathway.
    Wei Y; Liao Y; Deng Y; Zu Y; Zhao B; Li F
    Onco Targets Ther; 2019; 12():9005-9016. PubMed ID: 31802909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. microRNA-605 Inhibits the Oncogenicity of Non-Small-Cell Lung Cancer by Directly Targeting Forkhead Box P1 [Retraction].
    Onco Targets Ther; 2021; 14():4933-4934. PubMed ID: 34611411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-936 Targets FGF2 to Inhibit Epithelial Ovarian Cancer Aggressiveness by Deactivating the PI3K/Akt Pathway [Retraction].
    Onco Targets Ther; 2021; 14():4961-4962. PubMed ID: 34675537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. microRNA-605 Directly Targets SOX9 to Alleviate the Aggressive Phenotypes of Glioblastoma Multiforme Cell Lines by Deactivating the PI3K/Akt Pathway [Retraction].
    Onco Targets Ther; 2021; 14():4739-4740. PubMed ID: 34526778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing of Long Non-Coding RNA-HCG18 Inhibits the Tumorigenesis of Gastric Cancer Through Blocking PI3K/Akt Pathway [Retraction].
    Onco Targets Ther; 2020; 13():12195. PubMed ID: 33273823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-761 Targets FGFR1 to Suppress the Malignancy of Osteosarcoma by Deactivating PI3K/Akt Pathway [Retraction].
    Onco Targets Ther; 2021; 14():4937-4938. PubMed ID: 34611413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-126 Regulates Proliferation and Invasion in the Bladder Cancer BLS Cell Line by Targeting the PIK3R2-Mediated PI3K/Akt Signaling Pathway [Retraction].
    Onco Targets Ther; 2021; 14():1859. PubMed ID: 33732003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. microRNA-944 Inhibits the Malignancy of Hepatocellular Carcinoma by Directly Targeting IGF-1R and Deactivating the PI3K/Akt Signaling Pathway [Retraction].
    Cancer Manag Res; 2021; 13():4765. PubMed ID: 34163251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. microRNA-769 is Downregulated in Colorectal Cancer and Inhibits Cancer Progression by Directly Targeting Cyclin-Dependent Kinase 1 [Retraction].
    Onco Targets Ther; 2021; 14():4851-4852. PubMed ID: 34602822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-211 Promotes Non-Small-Cell Lung Cancer Proliferation and Invasion by Targeting MxA [Retraction].
    Onco Targets Ther; 2022; 15():1387-1388. PubMed ID: 36415851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GATA1 Gene Silencing Inhibits Invasion, Proliferation and Migration of Cholangiocarcinoma Stem Cells via Disrupting the PI3K/AKT Pathway [Retraction].
    Onco Targets Ther; 2021; 14():1005. PubMed ID: 33603406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of miR-204-5p Promotes Tumor Proliferation, Migration, and Invasion Through Targeting YWHAZ/PI3K/AKT Pathway in Esophageal Squamous Cell Carcinoma [Retraction].
    Onco Targets Ther; 2023; 16():801-802. PubMed ID: 37794861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. microRNA-612 Suppresses the Malignant Development of Non-Small-Cell Lung Cancer by Directly Targeting Bromodomain-Containing Protein 4 [Retraction].
    Onco Targets Ther; 2021; 14():4745-4746. PubMed ID: 34526781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microRNA-877 Inhibits Malignant Progression of Colorectal Cancer by Directly Targeting MTDH and Regulating the PTEN/Akt Pathway [Retraction].
    Cancer Manag Res; 2021; 13():7489-7490. PubMed ID: 34611442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-769-5p Inhibits Pancreatic Ductal Adenocarcinoma Progression by Directly Targeting and Downregulating ETS Proto-Oncogene 1 [Retraction].
    Onco Targets Ther; 2021; 14():4965-4966. PubMed ID: 34629880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-212 Inhibits Hepatocellular Carcinoma Cell Proliferation and Induces Apoptosis by Targeting FOXA1 [Retraction].
    Onco Targets Ther; 2022; 15():849-850. PubMed ID: 35975009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. microRNA-493 Inhibits Tongue Squamous Cell Carcinoma Oncogenicity via Directly Targeting HMGA2 [Retraction].
    Onco Targets Ther; 2021; 14():4737-4738. PubMed ID: 34526777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low expression of PDK1 inhibits renal cell carcinoma cell proliferation, migration, invasion and epithelial mesenchymal transition through inhibition of the PI3K-PDK1-Akt pathway.
    Zhou WM; Wu GL; Huang J; Li JG; Hao C; He QM; Chen XD; Wang GX; Tu XH
    Cell Signal; 2019 Apr; 56():1-14. PubMed ID: 30465826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.